RecruitingNCT07344714

Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting

Predicting Respiratory Distress Syndrome in Neonates Delivered in a Lower-Level NICU Setting

Sponsor

Mayo Clinic

Enrollment

500 participants

Start Date

Mar 11, 2026

Study Type

OBSERVATIONAL

Conditions

Transient Tachypnea of the Newborn Pneumothorax Respiratory Distress Syndrome in Premature Infant Respiratory Distress Syndrome, Newborn Pneumonia Neonatal Hyaline Membrane Disease Respiratory Distress Neonatal Meconium aspiration syndrome

Summary

The purpose of this study is to analyze the gastric fluid aspirated from the stomachs of neonates receiving routine post-delivery care to predict the need for prolonged respiratory support (\>6 hours of life).

Eligibility

Min Age: 32 WeeksMax Age: 41 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with hyaline membrane disease, meconium aspiration syndrome, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 32 Weeks to 41 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.